According to the FDA (2024), ceftazidime is a key agent for treating Pseudomonas aeruginosa due to its high stability against many bacterial beta-lactamases.
A study published in the Journal of Antimicrobial Chemotherapy (2022) highlighted that ceftazidime remains a first-line choice for healthcare-associated pneumonia in many international guidelines.
The World Health Organization (WHO, 2023) lists ceftazidime on its Model List of Essential Medicines, signifying its importance to a basic healthcare system.
Clinical data from DailyMed (2024) indicates that up to 90% of a ceftazidime dose is excreted unchanged by the kidneys, necessitating careful dosing in renal patients.
Research in the American Journal of Health-System Pharmacy (2021) notes that ceftazidime can cause neurotoxicity, including seizures, if not dose-adjusted for decreased kidney function.
According to the CDC (2023), ceftazidime is frequently used in the empiric treatment of febrile neutropenia in cancer patients.
The FDA-approved labeling (2024) warns that there is a 5-10% chance of cross-reactivity in patients with a history of penicillin allergy.
A meta-analysis in Clinical Infectious Diseases (2022) confirmed that ceftazidime's efficacy is time-dependent, meaning maintaining blood levels above the MIC is critical for success.
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Ceftazidime, you must consult a qualified healthcare professional.
Ceftazidime is a potent third-generation cephalosporin antibiotic used primarily for serious bacterial infections, including those caused by Pseudomonas aeruginosa, by inhibiting bacterial cell wall synthesis.
💊Usage & Dosage
Adult Dosage
The dosage of ceftazidime depends on the severity of the infection, the susceptibility of the causative organism, and the patient's overall health status.
Standard Adult Dose: For most infections, the typical dose is 1 gram administered every 8 to 12 hours. This can be given via intravenous (IV) or intramuscular (IM) injection.
Urinary Tract Infections (UTIs): For uncomplicated infections, 250 mg every 12 hours may be sufficient. For complicated UTIs, 500 mg to 1 gram every 8 to 12 hours is common.
Severe or Life-Threatening Infections: For conditions like meningitis or severe pseudomonal infections, the dose may be increased to 2 grams every 8 hours.
Bone and Joint Infections: Typically 2 grams IV every 12 hours.
Cystic Fibrosis Patients: Because patients with cystic fibrosis clear the drug more quickly, they may require higher doses, such as 30 to 50 mg/kg every 8 hours, up to a maximum of 6 grams per day.
Pediatric Dosage
Ceftazidime is approved for use in pediatric patients, including neonates. Dosing is strictly weight-based.
Neonates (0-4 weeks): 30 mg/kg every 12 hours.
Infants and Children (1 month to 12 years): The typical dose is 30 to 50 mg/kg every 8 hours. The maximum daily dose for children should generally not exceed 6 grams.
Specific Infections: For pediatric meningitis or severe infections, healthcare providers may use the higher end of the dosing range (50 mg/kg every 8 hours).
Dosage Adjustments
Renal Impairment
Since ceftazidime is primarily excreted by the kidneys, the dose must be adjusted for patients with decreased kidney function to prevent toxic accumulation. Adjustments are based on Creatinine Clearance (CrCl):
CrCl 31–50 mL/min: 1 gram every 12 hours.
CrCl 16–30 mL/min: 1 gram every 24 hours.
CrCl 6–15 mL/min: 500 mg every 24 hours.
CrCl < 5 mL/min: 500 mg every 48 hours.
Hemodialysis Patients: A loading dose of 1 gram is followed by 1 gram after each dialysis session.
Hepatic Impairment
No dosage adjustment is typically required for patients with liver disease, as ceftazidime is not metabolized by the liver. However, clinical monitoring remains important in patients with multi-organ failure.
Elderly Patients
Older adults often have reduced renal function even if their serum creatinine levels appear normal. Healthcare providers typically use lower doses or longer intervals between doses for geriatric patients and monitor kidney function closely.
How to Take Ceftazidime
Ceftazidime is administered by healthcare professionals in a hospital or clinic setting. If you are receiving this medication at home through an outpatient parenteral antibiotic therapy (OPAT) program:
Administration: It is given as an injection into a large muscle (IM) or through a vein (IV) as a slow injection or a continuous infusion over 30 minutes.
Preparation: The powder must be dissolved with a sterile diluent (like sterile water or saline). During mixing, carbon dioxide gas is released, which may cause the pressure in the vial to increase. This is normal.
Storage: Reconstituted solutions should be used immediately or stored in the refrigerator as directed by the manufacturer. Do not use the solution if it is cloudy or contains particles.
Completing the Course: It is vital to finish the entire course of treatment as prescribed, even if you feel better. Stopping early can allow the remaining bacteria to multiply and develop resistance.
Missed Dose
In a hospital setting, nurses will manage the schedule. If you are self-administering at home and miss a dose, contact your healthcare provider or pharmacist immediately. Do not double the dose to catch up. Maintaining a consistent level of the drug in your blood is critical for killing the bacteria.
Overdose
Symptoms of ceftazidime overdose can include seizures, encephalopathy (brain dysfunction), neuromuscular excitability, and coma, especially in patients with kidney disease. If an overdose is suspected, emergency medical treatment is required. Hemodialysis can be used to help remove the drug from the blood more quickly.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance.
⚠️Side Effects
Common Side Effects (>1 in 10)
While most patients tolerate ceftazidime well, some common side effects may occur. These are usually mild and often resolve as the body adjusts to the medication or once the treatment is finished.
Local Site Reactions: Because the drug is given by injection, many patients experience pain, redness, or swelling at the injection site. If given intravenously, phlebitis (inflammation of the vein) can occur, which may feel like a warm, tender cord under the skin.
Gastrointestinal Issues: Diarrhea is the most frequently reported systemic side effect. Some patients may also experience nausea or vomiting. These symptoms usually occur because the antibiotic disrupts the balance of 'good' bacteria in the gut.
Dermatologic Reactions: A mild skin rash or itching (pruritus) may occur. This is often a localized reaction and may not necessarily indicate a severe allergy, though it should always be reported to a doctor.
🔴Warnings
Important Safety Information
Ceftazidime is a potent medication that requires careful clinical oversight. Before starting treatment, patients must inform their healthcare provider of their complete medical history, particularly any history of allergies to antibiotics. Because ceftazidime is cleared by the kidneys, any history of renal disease is a critical piece of information that will dictate the dosing schedule. Furthermore, patients should be aware that while ceftazidime is highly effective against bacteria, it has no effect on viral or fungal infections unless specifically combined with other agents.
Black Box Warnings
No FDA black box warnings for Ceftazidime.
Major Precautions
Allergic Reactions / Anaphylaxis Risk: There is a significant risk of cross-reactivity between cephalosporins and penicillins. Approximately 5% to 10% of patients with a documented penicillin allergy may also be allergic to ceftazidime. If a patient has ever experienced a severe, immediate reaction (like hives or breathing trouble) to any beta-lactam antibiotic, ceftazidime should be used with extreme caution or avoided entirely.
🔄Interactions
Contraindicated Combinations (Do Not Use Together)
There are few absolute contraindications for drug combinations with ceftazidime, but specific live vaccines should be avoided.
Live Typhoid Vaccine: Antibiotics like ceftazidime can kill the live bacteria in the vaccine, rendering it ineffective. It is typically recommended to wait at least 3 days after finishing the antibiotic before receiving a live bacterial vaccine.
Live BCG Vaccine: Similar to the typhoid vaccine, the efficacy of the BCG vaccine (used for tuberculosis or bladder cancer) is significantly reduced by concurrent antibiotic therapy.
Serious Interactions (Monitor Closely)
Aminoglycosides (e.g., Gentamicin, Amikacin): When used together, there is an increased risk of nephrotoxicity (kidney damage). While these drugs are often combined to treat severe
🚫Contraindications
Absolute Contraindications
Absolute contraindications are conditions under which ceftazidime must never be used because the risks significantly outweigh any potential benefits.
Hypersensitivity to Ceftazidime: If a patient has a documented history of an allergic reaction to ceftazidime itself, its use is strictly forbidden.
Severe Cephalosporin Allergy: Patients who have experienced anaphylaxis, Stevens-Johnson Syndrome, or other life-threatening reactions to any other cephalosporin (such as cephalexin, ceftriaxone, or cefazolin) should not receive ceftazidime.
Immediate Hypersensitivity to Penicillins: While many penicillin-allergic patients can take cephalosporins, those with a history of Type I reactions (anaphylaxis, angioedema, or bronchospasm) to penicillin are at high risk for cross-reactivity and should generally avoid ceftazidime unless no other options exist and the first dose is given under extreme medical supervision.
👥Special Populations
Pregnancy
Ceftazidime is classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
First Trimester: As with all medications, use during the first trimester should be limited to cases where it is clearly necessary.
Risk-Benefit: Ceftazidime is generally considered one of the safer antibiotics to use during pregnancy if a severe bacterial infection is present. Untreated infections (like a kidney infection) often pose a much greater risk to both the mother and the fetus than the medication itself.
Teratogenicity: Current data does not suggest that ceftazidime causes birth defects.
Breastfeeding
🧬Pharmacology
Mechanism of Action
Ceftazidime is a bactericidal antibiotic. Its molecular mechanism involves the inhibition of bacterial cell wall synthesis. Specifically, ceftazidime acts as a structural analog of the D-alanyl-D-alanine end of the peptidoglycan precursor. This allows it to compete for the active site of Penicillin-Binding Proteins (PBPs), particularly PBP-3 in Gram-negative organisms.
By covalently binding to these PBPs, ceftazidime prevents the transpeptidation step (the cross-linking of peptidoglycan chains). Without this cross-linking, the bacterial cell wall loses its structural integrity. The bacteria's own autolytic enzymes (autolysins) then continue to break down the wall, leading to cell rupture and death. Ceftazidime is highly stable against many beta-lactamases (enzymes produced by bacteria to destroy antibiotics), which allows it to remain effective against many resistant strains.
Pharmacodynamics
The efficacy of ceftazidime is time-dependent. This means that the most important factor for killing bacteria is the amount of time that the concentration of the drug in the blood remains above the Minimum Inhibitory Concentration (MIC) of the specific bacteria being treated. This is why the drug is given in divided doses (every 8 or 12 hours) or sometimes as a continuous infusion.
Frequently Asked Questions
Common questions about Ceftazidime
What is Ceftazidime used for?
Ceftazidime is a powerful antibiotic used to treat a variety of serious bacterial infections, particularly those caused by difficult-to-treat Gram-negative bacteria. Healthcare providers commonly prescribe it for hospital-acquired pneumonia, complicated urinary tract infections, and skin or bone infections. It is also a critical treatment for septicemia, which is a life-threatening blood infection. One of its most important uses is treating infections caused by *Pseudomonas aeruginosa*, an organism often resistant to other antibiotics. It is only used for bacterial infections and will not work for viral illnesses like the flu.
What are the most common side effects of Ceftazidime?
The most frequent side effects reported by patients taking ceftazidime include local reactions at the injection site, such as pain, swelling, or redness. Gastrointestinal issues like diarrhea, nausea, and vomiting are also common as the antibiotic affects gut bacteria. Some patients may develop a mild skin rash or experience a headache or dizziness. While these are usually mild, more severe diarrhea should be reported to a doctor immediately. Most of these symptoms resolve once the course of treatment is completed.
Can I drink alcohol while taking Ceftazidime?
While ceftazidime does not have a direct, dangerous interaction with alcohol like some other antibiotics, it is generally best to avoid alcohol while being treated for a serious infection. Alcohol can interfere with your body's ability to heal, cause dehydration, and potentially worsen side effects like dizziness or nausea. Additionally, alcohol can stress the liver and immune system when they are already working hard to fight an infection. Always check with your healthcare provider for specific guidance based on your overall health. It is important to stay well-hydrated with water and clear fluids during your recovery.
Is Ceftazidime safe during pregnancy?
Ceftazidime is generally considered safe for use during pregnancy and is classified as FDA Category B. Animal studies have not shown harm to the fetus, although there are limited high-quality studies in pregnant humans. Doctors typically prescribe it during pregnancy only when the benefit of treating a severe infection outweighs any potential risks. Untreated bacterial infections in a pregnant woman can lead to serious complications for both the mother and the baby. If you are pregnant or planning to become pregnant, ensure your doctor is aware before starting this medication. They will help weigh the risks and benefits for your specific situation.
How long does it take for Ceftazidime to work?
Ceftazidime begins working almost immediately after it is injected into the vein or muscle, as it reaches peak levels in the bloodstream very quickly. However, most patients do not start to feel a significant improvement in their symptoms for 24 to 48 hours. The time it takes to feel better depends on the severity of the infection and the type of bacteria involved. Even if you feel better within a few days, it is crucial to complete the entire course of treatment. Stopping the medication too early can lead to the infection returning and may contribute to antibiotic resistance.
Can I stop taking Ceftazidime suddenly?
You should never stop taking ceftazidime suddenly without consulting your healthcare provider, even if you feel completely recovered. Antibiotics must be taken for the full duration prescribed to ensure that every single bacterium causing the infection is killed. If you stop the treatment early, the strongest bacteria may survive, multiply, and cause the infection to return. Furthermore, these surviving bacteria are more likely to become resistant to ceftazidime in the future. If you are experiencing bothersome side effects, talk to your doctor about how to manage them rather than stopping the drug.
What should I do if I miss a dose of Ceftazidime?
If you are receiving ceftazidime in a hospital, your medical team will handle the dosing schedule for you. If you are administering the medication at home and miss a dose, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Never double the dose to make up for a missed one, as this can increase the risk of side effects like seizures. Consistency is key to keeping enough of the drug in your system to fight the infection effectively.
Does Ceftazidime cause weight gain?
Ceftazidime is not known to cause weight gain. It is typically used for short-term treatment of acute infections, which is not a timeframe usually associated with medication-induced weight changes. In fact, some patients may lose a small amount of weight during treatment due to a loss of appetite from the infection itself or gastrointestinal side effects like nausea or diarrhea. If you notice significant or rapid weight changes while taking this medication, you should contact your healthcare provider. This could be a sign of other issues, such as fluid retention related to kidney function.
Can Ceftazidime be taken with other medications?
Ceftazidime can interact with several other medications, so it is vital to provide your doctor with a full list of what you are taking. It may increase the risk of kidney damage if taken with aminoglycoside antibiotics or strong diuretics like furosemide. It can also interfere with the effectiveness of oral contraceptives and the live typhoid vaccine. If you are taking blood thinners like warfarin, ceftazidime may increase your risk of bleeding, requiring more frequent monitoring. Always discuss all prescriptions, over-the-counter drugs, and herbal supplements with your medical team.
Is Ceftazidime available as a generic?
Yes, ceftazidime is available as a generic medication and is produced by several different pharmaceutical manufacturers. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the original brand-name versions (such as Fortaz or Tazicef). Because it is a generic, it is often more affordable for hospitals and patients. The availability of a generic version helps ensure that this essential antibiotic remains accessible for treating serious infections. Your healthcare provider will prescribe the version that is most appropriate and available at your treatment facility.
Similar Medications
Other drugs with the same active ingredient (Ceftazidime)
Fever and Chills: Some patients may develop a 'drug fever' shortly after administration.
Dizziness and Headache: A feeling of lightheadedness or a dull ache in the head may occur.
Paresthesia: A 'pins and needles' sensation or numbness in the extremities.
Oral Candidiasis (Thrush): An overgrowth of yeast in the mouth, appearing as white patches on the tongue or inner cheeks, due to the suppression of normal oral bacteria.
Vaginitis: Yeast infections in women may occur for similar reasons.
Rare Side Effects (less than 1 in 100)
Hematologic Changes: These include eosinophilia (increased white blood cells), thrombocytosis (increased platelets), or leukopenia (decreased white blood cells). These are typically discovered during routine blood tests.
Positive Coombs' Test: Ceftazidime can cause a patient to develop a positive direct Coombs' test, which can sometimes interfere with blood cross-matching procedures.
Hepatic Enzyme Elevations: Temporary increases in liver enzymes (ALT, AST, alkaline phosphatase) may occur, though clinical liver damage is rare.
Serious Side Effects — Seek Immediate Medical Attention
> Warning: Stop taking Ceftazidime and call your doctor immediately if you experience any of these symptoms.
Anaphylaxis (Severe Allergic Reaction): Symptoms include swelling of the face, lips, or tongue; difficulty breathing or swallowing; severe hives; and a rapid drop in blood pressure (fainting or extreme dizziness).
Clostridioides difficile-Associated Diarrhea (CDAD): This is a severe infection of the colon. Symptoms include watery or bloody diarrhea (at least three times a day), severe stomach cramping, and fever. This can occur even two months after the antibiotic course is finished.
Neurotoxicity: Especially in those with kidney disease, ceftazidime can cause seizures, encephalopathy (confusion, altered mental status), or myoclonus (involuntary muscle jerks). This occurs when drug levels in the brain become too high.
Severe Skin Reactions: Such as Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). Watch for flu-like symptoms followed by a painful red or purplish rash that spreads and blisters, leading to the top layer of skin peeling off.
Renal Failure: Signs include a significant decrease in urine output, swelling in the legs or ankles, and fatigue.
Long-Term Side Effects
Prolonged use of ceftazidime (over several weeks) may lead to:
Superinfection: This is an infection that occurs during the treatment of another infection. It happens when non-susceptible bacteria or fungi overgrow because the antibiotic has killed off the competing normal flora.
Antibiotic Resistance: Extended use increases the risk that the bacteria being treated will adapt and become resistant to ceftazidime and other cephalosporins.
Chronic Kidney Stress: In patients with borderline renal function, long-term therapy requires frequent monitoring to prevent cumulative nephrotoxicity.
Black Box Warnings
There are currently no FDA black box warnings for ceftazidime. However, there are significant 'Warnings and Precautions' regarding hypersensitivity and neurotoxicity that carry nearly the same clinical weight in practice.
Report any unusual symptoms to your healthcare provider immediately. Early intervention is key to managing side effects effectively.
Neurotoxicity: This is a major concern for patients with renal impairment. If the dose is not properly reduced, ceftazidime can accumulate in the central nervous system, leading to life-threatening neurological events including seizures, nonconvulsive status epilepticus, and coma. Healthcare providers must monitor mental status closely in patients with poor kidney function.
Clostridioides difficile-Associated Diarrhea (CDAD): Like nearly all broad-spectrum antibiotics, ceftazidime can alter the normal flora of the colon, allowing the overgrowth of C. difficile. This bacterium produces toxins that can lead to life-threatening pseudomembranous colitis. Patients should never use anti-diarrheal medications (like loperamide) if they develop diarrhea while taking ceftazidime, as this can trap toxins in the gut and worsen the condition.
Development of Drug-Resistant Bacteria: Prescribing ceftazidime in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit and increases the risk of the development of drug-resistant bacteria.
Monitoring Requirements
Patients receiving ceftazidime, especially for prolonged periods or at high doses, require regular laboratory monitoring:
Renal Function Tests: Serum creatinine and Blood Urea Nitrogen (BUN) should be checked frequently to ensure the kidneys are clearing the drug and to adjust the dose if function declines.
Complete Blood Count (CBC): To monitor for potential (though rare) effects on white blood cells, red blood cells, and platelets.
Liver Function Tests (LFTs): To monitor for transient elevations in liver enzymes.
Prothrombin Time (PT/INR): In patients at risk for vitamin K deficiency (e.g., those with poor nutrition or chronic liver disease), cephalosporins can occasionally interfere with blood clotting.
Driving and Operating Machinery
Ceftazidime generally does not interfere with the ability to drive or operate machinery. However, if a patient experiences side effects like dizziness, confusion, or seizures (neurotoxicity), they should avoid these activities until the symptoms have completely resolved and they have been cleared by a doctor.
Alcohol Use
While ceftazidime does not typically cause a 'disulfiram-like reaction' (nausea, vomiting, flushing) when combined with alcohol—unlike some other cephalosporins like cefotetan—it is generally advised to avoid alcohol during any severe infection. Alcohol can dehydrate the body and weaken the immune system, potentially slowing the recovery process.
Discontinuation
Ceftazidime does not have a withdrawal syndrome and does not require a tapering period. However, the most significant risk of discontinuation is stopping the medication too early. If the full course is not completed, the infection may return, and the surviving bacteria may be more resistant to treatment.
> Important: Discuss all your medical conditions with your healthcare provider before starting Ceftazidime. Transparency about your health history ensures the safest possible treatment outcome.
Pseudomonas
infections (synergy), the patient's renal function must be monitored daily.
Potent Diuretics (e.g., Furosemide/Lasix): High doses of 'loop' diuretics can increase the risk of kidney damage when taken with cephalosporins. This combination requires careful monitoring of hydration and kidney labs.
Chloramphenicol: Some studies suggest that chloramphenicol may act as an antagonist to beta-lactam antibiotics like ceftazidime. This means the two drugs might cancel each other out, making the treatment less effective. This combination is generally avoided.
Moderate Interactions
Oral Contraceptives: Like many broad-spectrum antibiotics, ceftazidime may theoretically reduce the effectiveness of birth control pills by altering the gut bacteria responsible for recycling estrogen. While the clinical risk is considered low, many providers recommend using a backup method (like condoms) during treatment.
Warfarin (Coumadin): Cephalosporins can inhibit the production of Vitamin K by gut bacteria. This can enhance the blood-thinning effects of Warfarin, leading to an increased risk of bleeding. Patients on Warfarin should have their INR monitored more frequently when starting or stopping ceftazidime.
Probenecid: Unlike penicillins, the renal excretion of ceftazidime is NOT significantly affected by probenecid. However, it is still worth noting in a clinical context as it is a common interaction for other drugs in this class.
Food Interactions
Since ceftazidime is administered by injection, food does not affect its absorption. There are no specific restrictions regarding dairy, grapefruit, or high-fat meals. However, maintaining adequate hydration (drinking plenty of water) is important to help the kidneys flush the medication from the system.
Herbal/Supplement Interactions
Vitamin K: Since ceftazidime can lower Vitamin K levels, taking a Vitamin K supplement might interfere with the intended effect if a doctor is trying to manage clotting, though this is rare.
Probiotics: While probiotics can help prevent antibiotic-associated diarrhea, they should be taken at least 2 hours apart from the ceftazidime dose to ensure the antibiotic doesn't kill the beneficial bacteria in the supplement immediately.
Lab Test Interactions
Urinary Glucose Tests: Ceftazidime can cause a false-positive result for glucose (sugar) in the urine when using copper reduction tests (like Benedict's solution or Clinitest). It does not affect glucose tests based on enzymatic reactions (like Clinistix).
Coombs' Test: As mentioned previously, ceftazidime can cause a positive direct antiglobulin (Coombs') test, which can complicate blood typing and cross-matching for blood transfusions.
Creatinine Tests: High concentrations of ceftazidime can interfere with the Jaffé method of measuring serum creatinine, potentially resulting in artificially high readings. This can lead to incorrect assumptions about a patient's kidney function.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter items can influence how your body responds to ceftazidime.
Relative Contraindications
Relative contraindications require a careful risk-benefit analysis by the healthcare provider.
Pre-existing Renal Impairment: While not an absolute contraindication, the presence of kidney disease requires significant dose modification. If the dose is not adjusted, the risk of neurotoxicity (seizures) becomes unacceptably high.
History of Gastrointestinal Disease (Colitis): Patients with a history of inflammatory bowel disease or previous C. difficile infections are at a higher risk of developing severe antibiotic-associated colitis and must be monitored closely.
Seizure Disorders: Because ceftazidime can lower the seizure threshold (especially if kidney function is poor), it should be used with caution in patients with epilepsy or other central nervous system disorders.
Poor Nutritional Status: Patients who are malnourished or have Vitamin K deficiencies are at a higher risk of bleeding complications when taking cephalosporins.
Cross-Sensitivity
Cross-sensitivity refers to the potential for an allergic reaction to one substance to trigger a reaction to a related substance.
Beta-Lactam Antibiotics: This group includes penicillins, cephalosporins, carbapenems (like meropenem), and monobactams (like aztreonam). Because they share a similar chemical structure (the beta-lactam ring), the immune system may recognize all of them as 'the same.'
Specific Side-Chain Similarity: Ceftazidime shares a similar chemical side-chain with aztreonam. Therefore, patients allergic to aztreonam may have a higher risk of being allergic to ceftazidime compared to other cephalosporins.
> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing Ceftazidime.
Ceftazidime is excreted in human milk in low concentrations.
Effects on Infant: The amount of drug a nursing infant would receive is typically very small. However, potential risks include changes in the infant's gut flora (leading to diarrhea or thrush) and the potential for the infant to become sensitized (allergic) to the drug.
Clinical Recommendation: The American Academy of Pediatrics considers many cephalosporins compatible with breastfeeding. However, mothers should monitor their infants for diarrhea or diaper rash and consult their pediatrician.
Pediatric Use
Ceftazidime is widely used and approved for pediatric patients, including neonates and infants.
Safety: It has a well-established safety profile in children.
Dosing: Dosing must be carefully calculated based on weight (mg/kg).
Special Considerations: In neonates, the kidneys are not fully developed, so the interval between doses is typically longer (every 12 hours instead of every 8 hours).
Geriatric Use
Clinical studies have shown that elderly patients (65 and older) are at an increased risk of side effects from ceftazidime, primarily due to age-related declines in kidney function.
Renal Clearance: Because the drug is cleared by the kidneys, and renal function naturally decreases with age, the half-life of ceftazidime is often doubled in the elderly.
Neurotoxicity: There have been numerous reports of confusion and seizures in elderly patients given standard adult doses of ceftazidime without adjustment for their actual renal function.
Monitoring: Providers should check a 'calculated' creatinine clearance rather than just looking at the serum creatinine level in older adults.
Renal Impairment
This is the most critical special population for ceftazidime.
GFR-Based Adjustments: Dosing intervals must be extended as the Glomerular Filtration Rate (GFR) drops.
Dialysis: Ceftazidime is removed by hemodialysis. A supplemental dose is required after each session to maintain therapeutic levels. It is not significantly removed by peritoneal dialysis.
Hepatic Impairment
Patients with liver disease (cirrhosis or hepatitis) generally do not require dose adjustments for ceftazidime. However, if a patient has both liver and kidney failure, the renal dosing guidelines take precedence, and extreme caution is required.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing.
Solubility: Soluble in water and methanol; slightly soluble in alcohol.
Structure: Ceftazidime contains a beta-lactam ring fused to a six-membered dihydrothiazine ring. It features a complex C-7 side chain that provides resistance to beta-lactamases and a pyridinium group at the C-3 position, which enhances its activity against Pseudomonas.
Drug Class
Ceftazidime is a Third-Generation Cephalosporin. It is related to other antibiotics like ceftriaxone (Rocephin) and cefotaxime (Claforan). However, ceftazidime is unique within this class for its superior activity against Pseudomonas aeruginosa, whereas ceftriaxone is generally more active against Gram-positive organisms like Streptococcus pneumoniae.